Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve

introduced

No lobbying positions or financial data recorded for this regulation yet.

Public comment data and advocacy positions are added as they become available.